Jazz Pharma has bolstered its pipeline of cancer drugs through a $1.3 billion licensing agreement with Werewolf Therapeutics that adds its first immuno-oncology candidate. The Dublin-based pharma is ...
secrets to healthier living: transform your home into your own retreat centre for a quick detox, or enjoy eco-friendly ...
News headlines Wolfspeed is making significant strides in the silicon carbide market, highlighted by a recent $698 million tax refund that enhances its liquidity and operational capabilities. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results